Tai-Li Chang
Kalehua Capital Management Llc
Assets Managed
$259.946M
Holdings
25
Last Quarter
2026 - Q1
Filed Date
7d ago
Growth Rate
157.12%(2Q avg: 78.56%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Kalehua Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 25 positions.
Assets under management
The assets under management (AUM) of Kalehua Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 259.946M in assets, with a quarterly growth rate of 157.12% and a 2-quarter average growth rate of 78.56%. The portfolio is managed by Tai-Li Chang, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
BOXX Alpha Architect 1-3 Mnth Box
| 15.07% | $39.155M 336,700 shares@ $116.29 avg price | Increased 45.9% |
XFOR X4 Pharmaceuticals Inc
| 11.83% | $30.751M 7.446M shares@ $4.13 avg price | Increased 100% |
SRZN Surrozen Inc
| 8.64% | $22.44M 770,356 shares@ $29.13 avg price | Increased 100% |
RLAY Relay Therapeutics Inc
| 6.91% | $17.939M 1.803M shares@ $9.95 avg price | Increased 100% |
SION Sionna Therapeutics Inc
| 6.08% | $15.801M 394,144 shares@ $40.09 avg price | Increased 100% |
MANE Veradermics Inc
| 6.04% | $15.697M 248,574 shares@ $63.15 avg price | New Position |
ACRS Aclaris Therapeutics Inc
| 4.58% | $11.887M 3.17M shares@ $3.76 avg price | New Position |
ORKA Oruka Therapeutics Inc
| 4.48% | $11.627M 237,048 shares@ $49.05 avg price | Increased 100% |
PHVS Pharvaris Nv
| 4.33% | $11.231M 397,544 shares@ $28.25 avg price | Increased 100% |
IKT Inhibikase Therapeutics Inc
| 4.2% | $10.911M 6.494M shares@ $1.68 avg price | Increased 271.12% |
1-10 of 25